Medicine for curing hepatitis

Abstract

The invention discloses a medicine for curing liver diseases, the key points of which are that the medicine of the invention is a honeyed pill prepared by carbonizing the medicine materials such as pangolin, tortoise shell, horse bezoar, endothelium corneum gigeriae galli, ochre, and so on. The medicine of the invention has the functions of reinforcing the stomach function, promoting digestion, relieving abdominal distention, activating and nourishing blood, nourishing Yin, suppressing Yang, benefiting the liver and kidneys, strengthening the bones, curing the hepatosplenomegaly, relieving convulsion, clearing fever and supplementing multiple elements damaged by the liver heat, and has a good curing effect in clearing away the humidity, fever and iceterus. A special carbonizing method is adopted, and the high incendiary carbonization of the medicine can achieve preferable variation of the medicine property, which not only increases the effect of the medicine in the digestion promotion, blood activation, Yin nourishment and humidity elimination to the greatest degree, but also effectively eliminates the toxins contained in the medicine and then achieves the medical aim of treating liver diseases, and meanwhile protects the liver from being damaged by the side effect of the medicine, thus achieving the aim of curing the liver diseases. The invention is reasonable in formulation, convenient in medicine taking, good in cure effect and has no toxic or side effects.

Description

1. Technical field [0001] The invention relates to a medicine for treating liver disease, especially a medicine for treating hepatitis B. 2. Background technology [0002] Liver disease and hepatitis B virus infection are caused by hepatitis B virus (HBV), a high-incidence infectious disease that is mainly caused by liver inflammatory lesions and can cause multiple organ damage. HBV infection is globally distributed, probably over half of the world's population has been infected, with 50 million new infections and 1 million deaths per year. About 5% of the world's population are chronic HBsAg carriers. In December 1995, the Ministry of Health conducted the second national survey; the average HBsAg positive carrier rate of the national population was 9.75% by radioimmunoassay, 11% of men, significantly higher than 8% of women, and 10% of rural areas were significantly higher. 8% higher than the city. The annual increase rate of the 1-5 year old group was significantly high...

AI Technical Summary

Problems solved by technology

To treat liver disease, if you only use medicines for "liver" diseases, it will inevitably cause damage to the liver body. Although within a certain period of time, the spread and reproduction of the liver virus can be temporarily restrained, but after a period of time, due to the effects of the medicine on the liver The damage to the body destroys the liver and its own defense system, leading to an imbalance in the liver's immune system, forcing the liver to produce antibodies, drug resistance, mutation, and recurrence, etc.